| In vitro | |||
---|---|---|---|---|
 | Beta | Peak point | Cut-off point | Branching parameter |
Seizure-like activity | −10.032 ± 0.379 | 22.8 ± 1.584 | 19.8 ± 5.954 | 1.317 ± 0.022 |
High bic (50 μM) | −8.6152 ± 0.837 | 44.2 ± 4.732* | 34.5 ± 7.445* | 1.322 ± 0.035 |
Oct (100 μM) | −9.710 ± 0.729 | 11.2 ± 1.018* | 11.5 ± 2.339* | 1.297 ± 0.041 |
Thalamic cut-off | −13.22 ± 0.053* | 13.4 ± 0.456* | 61.4 ± 5.341* | 1.358 ± 0.020 |
 | In vivo | |||
 | Beta | Peak point | Cut-off point | Branching parameter |
Spontaneous | −9.112 ± 0.512 | 21.9 ± 3.401 | 32.4 ± 1.147 | 1.221 ± 0.072 |
Seizure-like activity | −10.015 ± 0.692 | 24.8 ± 2.921 | 32.7 ± 1.098 | 1.329 ± 0.061 |
Thalamic lesion | −10.862 ± 0.462 | 26.3 ± 1.866 | 33 ± 0.912 | 1.365 ± 0.095 |